1122175

Eli Lilly & Company — FEI 1819470

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional Details

Sponsor, Contract Research Organization